1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [3ee5416a-797b-498d-b8f0-3ce46bcb97bc] => Array ( [runtime-id] => 3ee5416a-797b-498d-b8f0-3ce46bcb97bc [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [dfd16b02-10de-4958-ade9-b44ce12d1e44] => Array ( [runtime-id] => dfd16b02-10de-4958-ade9-b44ce12d1e44 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;7a3961c2e4438e05417a6618a8cc47465b60cd39 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [3ee5416a-797b-498d-b8f0-3ce46bcb97bc] => Array ( [runtime-id] => 3ee5416a-797b-498d-b8f0-3ce46bcb97bc [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [dfd16b02-10de-4958-ade9-b44ce12d1e44] => Array ( [runtime-id] => dfd16b02-10de-4958-ade9-b44ce12d1e44 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;7a3961c2e4438e05417a6618a8cc47465b60cd39 ) ) )Table 3:Clinical outcomes*
Combined (n = 16) IV rtPA (n = 13) P Value Successful recanalization (TIMI 2,3) 14 (88%) – Improvement of NIHSS score (24 hours) 11 ± 4.8 5 ± 4.3 .0007 Favorable outcome (mRS 0,1) (90 days) 10 (63%) 2 (15%) .022 Symptomatic ICH (36 hours) 0 1 (8%) Asymptomatic ICH (36 hours) 1 (6%) 0 Mortality (90 days) 1 (6%) 0
Note:—IV indicates intravenous; rtPA, recombinant tissue plasminogen activator; TIMI, Thrombolysis in Myocardial Infarction grade; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale; ICH, intracerebral hemorrhage.
* Data expressed as n (%) or mean ± SD.